Animal studies approved that overexpression of tumor suppressor, miR-7-1-3p, increased anti-tumor activities of silibinin (50 μM) and luteolin (20 μM) in RAPA pre-treated both U87MG and T98G tumors. This evidence concerns the gene TRERF1 and neoplasm.